摘要:
This invention provides a patch with less skin stimulation, excellent in long time store stability and heat stability and having favorable tack during use. The patch comprising a styrene - isoprene - styrene block copolymer, polyisobutylene, tackifier, plasticizer and pharmaceutically effective ingredient, in which two or more kinds of polyisobutylene of different average molecular weight are used in combination and the viscosity of the adhesive of the patch is between 1500 and 30,000 poise (at 60°C) and the tack of the patch is from 5 to 200 g/10 mm.
摘要:
This is an iontophoresis device preferred to detect abnormal conductivity at the beginning of energization and during energization. The iontophoresis device has a device (50) as a power source and the device (50) comprises an electric energy generating portion (60) generating electric energy, an output portion (70) outputting the electric energy, and an abnormal conductivity detecting portion (80) detecting whether or not the electric energy is supplied normally. The detecting action of the abnormal conductivity detecting portion (80) is carried out at the time of the non-output action of the output portion (70). During the energization, the output action by the output portion (70) and the detecting action by the abnormal conductivity detecting portion (80) are alternated in response to a command received from the microcomputer (12).
摘要:
A peroral pharmaceutical preparation releasable in the lower digestive tract, having a double-layer coating structure wherein a solid drug comprising a core containing an active ingredient is coated with an inner layer comprising a cationic polymer and an outer layer comprising an anionic polymer.
摘要:
A percutaneous administration patch medicine used to administer the medicine to a human body through the skin or mucous membrane, consisting of: (1) a backing layer nonpermeable to medicine components; (2) a medicine storage layer positioned on the lower side of the central portion of the backing layer and containing medicine components; (3) a protective film positioned on the lower side of the medicine storage layer and the circumferential portion of the backing layer, having cuts and nonpermeable to the medicine components; (4) a pressure sensitive adhesive layer positioned on the lower side of the protective film; and (5) a separable liner layer positioned on the lower side of the pressure sensitive adhesive layer and nonpermeable to the medicine components; the percutaneous administration patch medicine being capable of effectively minimizing the leakage and volatilization of medicine until the medicine has been administered to a patient through the skin, and maintaining the stability of the medicine during the preservation thereof.
摘要:
Medicinal compositions for colorectal cancer to be administered to the large intestine by taking advantage of preparations disintegrating in the large intestine, characterized by containing a cyclooxygenase inhibitor and an HMG-CoA reductase inhibitor. These compositions are appropriate for inhibiting the postoperative liver metastasis and recurrence of colorectal cancer.
摘要:
To avoid a reduction of the conductivity in iontophoresis due to the electrical decomposition and the changes in chemical properties of the electrodes themselves, covering by an electrical insulator, and to prevent a drop in the transport rate due to ions freed from the electrode. Provision is made of an electrode structure provided integrally with a reversible electrode and an auxiliary electrode for regeneration of the same and a regeneration current conducting means for conducting a current for regeneration of the reversible electrode when the therapeutic current is off, or the invention is comprised of a reversible electrode and an ion exchange membrane difficult for ions freed from that electrode to penetrate.
摘要:
A pernasal composition comprising a pharmacologically active substance, water and an alcohol, wherein the alcohol content is 10-70 vol. % of the whole composition. This composition is highly safe and permits rapid drug absorption and prolonged retention of blood drug level. Hence this composition and a pernasal preparation containing the same permit pernasal administration of drugs which have been difficult to administer pernasally and are expected to exhibit a satisfactory drug efficacy.